Creation of an NCI comparative brain tumor consortium: Informing the translation of new knowledge from canine to human brain tumor patients

Amy K. Leblanc, Christina Mazcko, Diane E. Brown, Jennifer W. Koehler, Andrew D. Miller, C. Ryan Miller, R. Timothy Bentley, Rebecca A. Packer, Matthew Breen, C. Elizabeth Boudreau, Jonathan M. Levine, R. Mark Simpson, Charles Halsey, William Kisseberth, John H. Rossmeisl, Peter J. Dickinson, Timothy M. Fan, Kara Corps, Kenneth Aldape, Vinay PuduvalliG. Elizabeth Pluhar, Mark R. Gilbert

Research output: Contribution to journalReview article

Abstract

On September 14-15, 2015, a meeting of clinicians and investigators in the fields of veterinary and human neuro-oncology, clinical trials, neuropathology, and drug development was convened at the National Institutes of Health campus in Bethesda, Maryland. This meeting served as the inaugural event launching a new consortium focused on improving the knowledge, development of, and access to naturally occurring canine brain cancer, specifically glioma, as a model for human disease. Within the meeting, a SWOT (strengths, weaknesses, opportunities, and threats) assessment was undertaken to critically evaluate the role that naturally occurring canine brain tumors could have in advancing this aspect of comparative oncology aimed at improving outcomes for dogs and human beings. A summary of this meeting and subsequent discussion are provided to inform the scientific and clinical community of the potential for this initiative. Canine and human comparisons represent an unprecedented opportunity to complement conventional brain tumor research paradigms, addressing a devastating disease for which innovative diagnostic and treatment strategies are clearly needed.

Original languageEnglish (US)
Pages (from-to)1209-1218
Number of pages10
JournalNeuro-Oncology
Volume18
Issue number9
DOIs
StatePublished - Sep 1 2016

Fingerprint

Translational Medical Research
Brain Neoplasms
Canidae
National Institutes of Health (U.S.)
Glioma
Research Personnel
Clinical Trials
Dogs
Research
Pharmaceutical Preparations
Therapeutics

Keywords

  • comparative oncology
  • glioma
  • translational research

ASJC Scopus subject areas

  • Oncology
  • Clinical Neurology
  • Cancer Research

Cite this

Leblanc, A. K., Mazcko, C., Brown, D. E., Koehler, J. W., Miller, A. D., Miller, C. R., ... Gilbert, M. R. (2016). Creation of an NCI comparative brain tumor consortium: Informing the translation of new knowledge from canine to human brain tumor patients. Neuro-Oncology, 18(9), 1209-1218. https://doi.org/10.1093/neuonc/now051

Creation of an NCI comparative brain tumor consortium : Informing the translation of new knowledge from canine to human brain tumor patients. / Leblanc, Amy K.; Mazcko, Christina; Brown, Diane E.; Koehler, Jennifer W.; Miller, Andrew D.; Miller, C. Ryan; Bentley, R. Timothy; Packer, Rebecca A.; Breen, Matthew; Boudreau, C. Elizabeth; Levine, Jonathan M.; Simpson, R. Mark; Halsey, Charles; Kisseberth, William; Rossmeisl, John H.; Dickinson, Peter J.; Fan, Timothy M.; Corps, Kara; Aldape, Kenneth; Puduvalli, Vinay; Pluhar, G. Elizabeth; Gilbert, Mark R.

In: Neuro-Oncology, Vol. 18, No. 9, 01.09.2016, p. 1209-1218.

Research output: Contribution to journalReview article

Leblanc, AK, Mazcko, C, Brown, DE, Koehler, JW, Miller, AD, Miller, CR, Bentley, RT, Packer, RA, Breen, M, Boudreau, CE, Levine, JM, Simpson, RM, Halsey, C, Kisseberth, W, Rossmeisl, JH, Dickinson, PJ, Fan, TM, Corps, K, Aldape, K, Puduvalli, V, Pluhar, GE & Gilbert, MR 2016, 'Creation of an NCI comparative brain tumor consortium: Informing the translation of new knowledge from canine to human brain tumor patients', Neuro-Oncology, vol. 18, no. 9, pp. 1209-1218. https://doi.org/10.1093/neuonc/now051
Leblanc, Amy K. ; Mazcko, Christina ; Brown, Diane E. ; Koehler, Jennifer W. ; Miller, Andrew D. ; Miller, C. Ryan ; Bentley, R. Timothy ; Packer, Rebecca A. ; Breen, Matthew ; Boudreau, C. Elizabeth ; Levine, Jonathan M. ; Simpson, R. Mark ; Halsey, Charles ; Kisseberth, William ; Rossmeisl, John H. ; Dickinson, Peter J. ; Fan, Timothy M. ; Corps, Kara ; Aldape, Kenneth ; Puduvalli, Vinay ; Pluhar, G. Elizabeth ; Gilbert, Mark R. / Creation of an NCI comparative brain tumor consortium : Informing the translation of new knowledge from canine to human brain tumor patients. In: Neuro-Oncology. 2016 ; Vol. 18, No. 9. pp. 1209-1218.
@article{275778ea000d4014a0fa4b30b54d97f1,
title = "Creation of an NCI comparative brain tumor consortium: Informing the translation of new knowledge from canine to human brain tumor patients",
abstract = "On September 14-15, 2015, a meeting of clinicians and investigators in the fields of veterinary and human neuro-oncology, clinical trials, neuropathology, and drug development was convened at the National Institutes of Health campus in Bethesda, Maryland. This meeting served as the inaugural event launching a new consortium focused on improving the knowledge, development of, and access to naturally occurring canine brain cancer, specifically glioma, as a model for human disease. Within the meeting, a SWOT (strengths, weaknesses, opportunities, and threats) assessment was undertaken to critically evaluate the role that naturally occurring canine brain tumors could have in advancing this aspect of comparative oncology aimed at improving outcomes for dogs and human beings. A summary of this meeting and subsequent discussion are provided to inform the scientific and clinical community of the potential for this initiative. Canine and human comparisons represent an unprecedented opportunity to complement conventional brain tumor research paradigms, addressing a devastating disease for which innovative diagnostic and treatment strategies are clearly needed.",
keywords = "comparative oncology, glioma, translational research",
author = "Leblanc, {Amy K.} and Christina Mazcko and Brown, {Diane E.} and Koehler, {Jennifer W.} and Miller, {Andrew D.} and Miller, {C. Ryan} and Bentley, {R. Timothy} and Packer, {Rebecca A.} and Matthew Breen and Boudreau, {C. Elizabeth} and Levine, {Jonathan M.} and Simpson, {R. Mark} and Charles Halsey and William Kisseberth and Rossmeisl, {John H.} and Dickinson, {Peter J.} and Fan, {Timothy M.} and Kara Corps and Kenneth Aldape and Vinay Puduvalli and Pluhar, {G. Elizabeth} and Gilbert, {Mark R.}",
year = "2016",
month = "9",
day = "1",
doi = "10.1093/neuonc/now051",
language = "English (US)",
volume = "18",
pages = "1209--1218",
journal = "Neuro-Oncology",
issn = "1522-8517",
publisher = "Oxford University Press",
number = "9",

}

TY - JOUR

T1 - Creation of an NCI comparative brain tumor consortium

T2 - Informing the translation of new knowledge from canine to human brain tumor patients

AU - Leblanc, Amy K.

AU - Mazcko, Christina

AU - Brown, Diane E.

AU - Koehler, Jennifer W.

AU - Miller, Andrew D.

AU - Miller, C. Ryan

AU - Bentley, R. Timothy

AU - Packer, Rebecca A.

AU - Breen, Matthew

AU - Boudreau, C. Elizabeth

AU - Levine, Jonathan M.

AU - Simpson, R. Mark

AU - Halsey, Charles

AU - Kisseberth, William

AU - Rossmeisl, John H.

AU - Dickinson, Peter J.

AU - Fan, Timothy M.

AU - Corps, Kara

AU - Aldape, Kenneth

AU - Puduvalli, Vinay

AU - Pluhar, G. Elizabeth

AU - Gilbert, Mark R.

PY - 2016/9/1

Y1 - 2016/9/1

N2 - On September 14-15, 2015, a meeting of clinicians and investigators in the fields of veterinary and human neuro-oncology, clinical trials, neuropathology, and drug development was convened at the National Institutes of Health campus in Bethesda, Maryland. This meeting served as the inaugural event launching a new consortium focused on improving the knowledge, development of, and access to naturally occurring canine brain cancer, specifically glioma, as a model for human disease. Within the meeting, a SWOT (strengths, weaknesses, opportunities, and threats) assessment was undertaken to critically evaluate the role that naturally occurring canine brain tumors could have in advancing this aspect of comparative oncology aimed at improving outcomes for dogs and human beings. A summary of this meeting and subsequent discussion are provided to inform the scientific and clinical community of the potential for this initiative. Canine and human comparisons represent an unprecedented opportunity to complement conventional brain tumor research paradigms, addressing a devastating disease for which innovative diagnostic and treatment strategies are clearly needed.

AB - On September 14-15, 2015, a meeting of clinicians and investigators in the fields of veterinary and human neuro-oncology, clinical trials, neuropathology, and drug development was convened at the National Institutes of Health campus in Bethesda, Maryland. This meeting served as the inaugural event launching a new consortium focused on improving the knowledge, development of, and access to naturally occurring canine brain cancer, specifically glioma, as a model for human disease. Within the meeting, a SWOT (strengths, weaknesses, opportunities, and threats) assessment was undertaken to critically evaluate the role that naturally occurring canine brain tumors could have in advancing this aspect of comparative oncology aimed at improving outcomes for dogs and human beings. A summary of this meeting and subsequent discussion are provided to inform the scientific and clinical community of the potential for this initiative. Canine and human comparisons represent an unprecedented opportunity to complement conventional brain tumor research paradigms, addressing a devastating disease for which innovative diagnostic and treatment strategies are clearly needed.

KW - comparative oncology

KW - glioma

KW - translational research

UR - http://www.scopus.com/inward/record.url?scp=84985994793&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84985994793&partnerID=8YFLogxK

U2 - 10.1093/neuonc/now051

DO - 10.1093/neuonc/now051

M3 - Review article

C2 - 27179361

AN - SCOPUS:84985994793

VL - 18

SP - 1209

EP - 1218

JO - Neuro-Oncology

JF - Neuro-Oncology

SN - 1522-8517

IS - 9

ER -